Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2016, Vol. 17 Issue (1): 54-59    DOI: 10.1631/jzus.B1500136
Article     
Trends in the prevalence of heart diseases over a ten-year period from single-center observations based on a large echocardiographic database
Hao Lu1,Wen-zhi Pan1,Quan Wan2,Lei-lei Cheng2,?(),Xian-hong Shu2,Cui-zhen Pan2,Ju-ying Qian1,Jun-bo Ge1,?()
1 Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
2 Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Download: HTML     PDF(464KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

There is a paucity of data regarding trends in the incidence of heart disease in China during recent years. Using a large echocardiography database in our center, we analyzed trends in the prevalence of several common heart diseases from Dec. 2003. This study retrospectively analyzed the echocardiographic database in our Department from 2003 to 2012. A total of 385 682 cases were included in the study. The prevalence of rheumatic heart disease decreased over the 10-year period, from 4.04% in 2003 to 3.06% in 2012 (P<0.01). Infective endocarditis also decreased, from a mean prevalence of 0.37% in July 2003 to 0.27% in Dec. 2008 (P<0.001). The prevalence of hypertrophic cardiomyopathy, which includes 20% apical hypertrophic cardiomyopathy and 20% hypertrophic obstructive cardiomyopathy, was about 1.8%. The prevalence of the three most common adult congenital heart diseases (CHDs) decreased by about 10% from July 2003 to Dec. 2008 (all P<0.001). The prevalence of moderate pulmonary arterial hypertension (PAH) or left ventricular systolic dysfunction (LVSD) decreased during the 10-year period (P<0.001), but there was no change in the prevalence of severe PAH or LVSD (P>0.05). The present study indirectly demonstrates that the prevalence of several common heart diseases in China has declined in recent years.



Key wordsPrevalence      Trends      Heart diseases      Epidemiology     
Received: 01 June 2015      Published: 01 January 2016
Fund:  Project supported by the National Natural Science Foundation of China(Nos. 81400318, 81300209)
Corresponding Authors: Lei-lei Cheng,Jun-bo Ge     E-mail: cheng.leilei@zs-hospital.sh.cn;jbge@zs-hospital.sh.cn
Cite this article:

Hao Lu,Wen-zhi Pan,Quan Wan,Lei-lei Cheng,Xian-hong Shu,Cui-zhen Pan,Ju-ying Qian,Jun-bo Ge. Trends in the prevalence of heart diseases over a ten-year period from single-center observations based on a large echocardiographic database. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(1): 54-59.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1500136     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2016/V17/I1/54

Year Number of case Male (%) Age (year) Total number of outpatient visits (person-time) Percentage of outpatient undergoing ECG (%)
2003 11 086 51.19 49.38±17.88 80 856 13.71
2004 14 656 52.32 54.39±16.06 103 526 14.16
2005 23 655 51.00 54.28±16.06 153 420 15.42
2006 28 210 50.54 54.81±16.36 184 755 15.27
2007 36 926 49.12 55.21±16.19 244 555 15.10
2008 46 414 49.94 55.47±18.61 293 538 15.81
2009 53 145 49.49 55.76±16.10 334 517 15.89
2010 54 247 51.42 55.87±15.84 375 271 14.45
2011 55 597 50.56 57.08±15.69 394 918 14.08
2012 61 746 51.80 57.10±16.50 423 561 14.57
Table 1 Demographic characteristics of outpatients undergoing transthoracic echocardiogram examination in our department from 2003 to 2012
Disease Prevalence of several common heart diseases (%)
Change* (%) P **
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 First 5 years Last 5 years
?RHD 4.04 5.49 3.73 3.71 3.43 3.11 2.91 3.10 3.05 3.06 3.87 3.04 ?21.47 <0.001
?IE 0.47 0.48 0.27 0.41 0.31 0.27 0.20 0.29 0.30 0.31 0.35 0.26 ?25.56 <0.001
?Post valve surgery 5.16 5.04 4.72 3.38 4.11 4.32 4.38 4.36 4.62 4.40 4.18 4.42 5.79 0.002
?Non-RHD VHD 4.66 5.15 5.01 4.27 4.27 4.33 3.82 4.64 4.54 4.65 4.67 4.33 ?7.68 0.006
?HOCM 0.32 0.42 0.37 0.37 0.33 0.29 0.37 0.42 0.48 0.45 0.37 0.40 8.41 0.008
?HNOCM 0.89 1.35 1.08 1.23 0.95 0.94 0.95 1.11 1.15 0.99 1.11 1.04 ?6.31 0.064
?ApHCM 0.39 0.33 0.34 0.32 0.25 0.16 0.29 0.52 0.33 0.69 0.30 0.33 10.01 0.202
?Total of HCM 1.60 2.10 1.79 1.92 1.53 1.39 1.61 2.05 2.17 2.14 1.78 1.76 ?1.12 0.784
?ARVD 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.02 0.00 0.01 67.96 0.370
?RCM 0.00 0.01 0.02 0.01 0.01 0.02 0.02 0.05 0.03 0.06 0.01 0.03 216.17 <0.001
?NCVM 0.02 0.05 0.02 0.04 0.03 0.02 0.05 0.08 0.06 0.04 0.04 0.05 36.83 0.016
?ASD 3.10 2.89 2.42 2.34 2.20 2.23 2.26 2.03 2.19 2.34 2.38 2.27 ?5.90 <0.001
?VSD 2.11 1.88 1.40 1.47 1.27 1.45 1.28 1.15 1.12 1.21 1.44 1.24 ?13.73 <0.001
?PDA 0.78 0.76 0.59 0.57 0.53 0.53 0.52 0.55 0.48 0.54 0.59 0.52 ?11.52 0.017
?ASD+VSD+PDA 5.99 5.53 4.40 4.39 4.00 4.21 4.07 4.09 3.80 4.09 4.41 3.94 ?10.82 <0.001
?BAV 0.65 0.85 0.61 0.74 0.55 0.62 0.74 0.79 0.90 1.08 0.65 0.72 9.24 0.058
?CHD associated PAH 1.71 1.30 1.14 1.22 1.02 0.91 0.85 0.82 0.83 0.97 1.14 0.85 ?25.65 <0.001
?Other types of PAH 7.73 9.40 5.50 7.58 6.82 5.70 3.64 6.22 5.98 6.06 7.09 5.39 ?24.01 <0.001
?Moderate PAH 7.48 8.54 6.64 7.09 6.18 5.09 4.79 5.21 5.01 5.31 6.87 5.02 ?26.87 <0.001
?Severe PAH 1.96 2.16 1.53 1.71 1.66 1.52 1.59 1.83 1.81 1.72 1.72 1.69 ?1.37 0.638
?Moderate LVSD 4.26 4.23 4.27 4.19 3.44 3.22 3.34 3.33 3.64 3.12 3.94 3.39 ?14.20 <0.001
?Severe LVSD 0.92 0.96 0.96 0.76 0.66 0.61 0.91 0.89 0.90 1.17 0.79 0.84 5.04 0.256
Table 2 Trends in the prevalence of several common heart diseases in China from 2003 to 2012
[1]   Douglas PS, Garcia MJ, Haines DE. Appropriate use criteria for echocardiography. J Am Soc Echocardiogr. 2011, 24(3):229-267. (Available from: http://dx.doi.org/10.1016/j.echo.2010.12.008)
doi: 10.1016/j.echo.2010.12.008
[2]   Chen HZ, Fan WH, Jin XJ. Changing trends of etiologic characteristics of cardiovascular diseases among inpatients in Shanghai: a retrospective observational study from 1948 to 1999. Chin J Intern Med. 2003, 42(12):829-832. (in Chinese)
pmid: 14728870
[3]   Eriksson MJ, Sonnenberg B, Woo A. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002, 39(4):638-645. (Available from: http://dx.doi.org/10.1016/S0735-1097(01)01778-8)
doi: 10.1016/S0735-1097(01)01778-8 pmid: 11849863
[4]   He J, Gu D, Wu X. Major causes of death among men and women in China. N Engl J Med. 2005, 353(11):1124-1134. (Available from: http://dx.doi.org/10.1056/NEJMsa050467)
doi: 10.1056/NEJMsa050467
[5]   Li J, Li X, Wang Q. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2014, 385(9966):441-451
[6]   Maron BJ, Gardin JM, Flack JM. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation. 1995, 92(4):785-789. (Available from: http://dx.doi.org/10.1161/01.CIR.92.4.785)
doi: 10.1161/01.CIR.92.4.785
[7]   Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971, 43(3):323-332. (Available from: http://dx.doi.org/10.1161/01.CIR.43.3.323)
doi: 10.1161/01.CIR.43.3.323 pmid: 5102136
[8]   Moro E, D'Angelo G, Nicolosi GL. Long-term evaluation of patients with apical hypertrophic cardiomyopathy. Correlation between quantitative echocardiographic assessment of apical hypertrophy and clinical-electrocardiographic findings. Eur Heart J. 1995, 16(2):210-217
[9]   NCCD (National Center for Cardiovascular Disease of China) Report on Cardiovascular Disease in China (2008–2009). 2010. Encyclopedia of China Publishing House. 7 (in Chinese)
[10]   Sakamoto T, Tei C, Murayama M. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976, 17(5):611-629. (Available from: http://dx.doi.org/10.1536/ihj.17.611)
doi: 10.1536/ihj.17.611 pmid: 136532
[11]   Warnes CA, Liberthson R, Danielson GK. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001, 37(5):1170-1175. (Available from: http://dx.doi.org/10.1016/S0735-1097(01)01272-4)
doi: 10.1016/S0735-1097(01)01272-4 pmid: 11300418
[12]   Wigle ED, Sasson Z, Henderson MA. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985, 28(1):1-83. (Available from: http://dx.doi.org/10.1016/0033-0620(85)90024-6)
doi: 10.1016/0033-0620(85)90024-6
[13]   World Health Organization. Preventing chronic diseases: a vital investment. 2005 Available from: [Accessed on Apr. 10, 2015]
[14]   World Health Organization. World health statistics 2009. 2009 Geneva: World Health Organization. Available from [Accessed on Apr. 10, 2015]
[15]   Yang G, Kong L, Zhao W. Emergence of chronic non-communicable diseases in China. Lancet. 2008, 372(9650):1697-1705. (Available from: http://dx.doi.org/10.1016/S0140-6736(08)61366-5)
doi: 10.1016/S0140-6736(08)61366-5 pmid: 18930526
[16]   Yang XY, Li XF, Lü XD. Incidence of congenital heart disease in Beijing, China. Chin Med J (Engl). 2009, 122(10):1128-11132
doi: 10.3760/cma.j.issn.0366-6999.2009.10.002 pmid: 19493457
[17]   Wang ZM, Zou YB, Song L. Prevalence of chronic rheumatic heart disease in Chinese adults. Int J Cardiol. 2006, 107(3):356-359. (Available from: http://dx.doi.org/10.1016/j.ijcard.2005.03.048)
doi: 10.1016/j.ijcard.2005.03.048 pmid: 16503258
[18]   Zoghbi WA, Enriquez-Sarano M, Foster E. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003, 16(7):777-802. (Available from: http://dx.doi.org/10.1016/S0894-7317(03)00335-3)
doi: 10.1016/S0894-7317(03)00335-3
[1] Yue Feng, Yue-mei Feng, Zhong-hua Zhang, Shao-xiong Wu, Du-bo Zhong, Chen-jian Liu. Prevalence and genotype of Chlamydia psittaci in faecal samples of birds from zoos and pet markets in Kunming, Yunnan, China[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(4): 311-316.
[2] Jian-nong Wu, Tie-er Gan, Yue-xian Zhu, Jun-min Cao, Cong-hua Ji, Yi-hua Wu, Bin Lv. Epidemiology and microbiology of nosocomial bloodstream infections: analysis of 482 cases from a retrospective surveillance study[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 70-77.
[3] Liang Liu, Qi-fan Xiao, Yan-li Zhang, Shu-kun Yao. A cross-sectional study of irritable bowel syndrome in nurses in China: prevalence and associated psychological and lifestyle factors[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 590-597.
[4] Xian-bao Liu, Jian-an Wang. Update of transcatheter valve treatment[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(8): 670-675.
[5] Yun-zhen Hu, Jian-wen Wang, Ben-yan Luo. Epidemiological and clinical characteristics of 266 cases of intracerebral hemorrhage in Hangzhou, China[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(6): 496-504.
[6] Feng-ying LI, Mao-de LAI. Colorectal cancer, one entity or three[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(3): 219-229.
[7] Ling-ling JIANG, Bing-ling ZHANG, You-shi LIU. Is adult celiac disease really uncommon in Chinese?[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(3): 168-171.
[8] Zong-zhao YANG, Jiang-bing SHUAI, Xian-jun DAI, Wei-huan FANG. A survey on porcine circovirus type 2 infection and phylogenetic analysis of its ORF2 gene in Hangzhou, Zhejiang Province, China[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(2): 148-153.